Hexarelin is a synthetic hexapeptide classified as a growth hormone secretagogue and ghrelin receptor agonist utilized extensively in endocrine and receptor-binding research models. Researchers evaluating hexarelin peptide procurement options must prioritize lot-specific analytical verification, structural integrity, and verified purity profiles. PX1 Research supplies high-grade research peptides manufactured in compliance with strict quality control frameworks for in vitro and laboratory applications.
Hexarelin is a synthetic hexapeptide classified as a growth hormone secretagogue and ghrelin receptor agonist utilized extensively in endocrine and receptor-binding research models. Researchers evaluating hexarelin peptide procurement options must prioritize lot-specific analytical verification, structural integrity, and verified purity profiles. PX1 Research supplies high-grade research peptides manufactured in compliance with strict quality control frameworks for in vitro and laboratory applications.
When evaluating options for hexarelin peptide procurement ("koop") for laboratory applications, researchers must select high-purity, synthetically manufactured hexapeptide lots verified via RP-HPLC and mass spectrometry. Hexarelin is a potent growth hormone secretagogue investigated in preclinical models for ghrelin receptor activation and somatotroph stimulation.
To maintain rigorous experimental reproducibility, analytical laboratories require reagents that are free from peptide fragments, trifluoroacetate (TFA) residual spikes, and bacterial endotoxins. Sourcing from accredited US-based facilities ensures batch-to-batch consistency and full analytical transparency via downloadable lot-specific certificates of analysis.
Hexarelin (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic hexapeptide derivative engineered to demonstrate enhanced enzymatic stability relative to endogenous ghrelin. Possessing a chemical formula of C47H58N12O6 and a molecular weight of 887.04 g/mol, the peptide incorporates unnatural D-amino acids within its sequence. This structural modification protects the peptide backbone against rapid cleavage by serine proteases and peptidases in culture media and tissue homogenates.
Unlike native ghrelin, Hexarelin does not require post-translational n-octanoylation at the serine-3 position to achieve high-affinity binding to its primary molecular targets. This structural independence simplifies synthetic production while allowing researchers to isolate ghrelin-receptor downstream signaling mechanisms without confounding esterase activity. When reviewing chemical suppliers for research peptides, verifying sequence identity via electrospray ionization mass spectrometry (ESI-MS) is essential to confirm molecular weight fidelity.
Preclinical studies indicate that Hexarelin functions as a high-affinity agonist at the growth hormone secretagogue receptor type 1a (GHSR-1a), a G-protein coupled receptor (GPCR) expressed densely within the anterior pituitary gland and hypothalamus. Binding of Hexarelin to GHSR-1a triggers intracellular signaling cascades mediated by phospholipase C (PLC), resulting in the generation of inositol trisphosphate (IP3) and diacylglycerol (DAG).
This pathway mobilizes intracellular calcium stores from the endoplasmic reticulum and activates protein kinase C (PKC), subsequently stimulating exocytosis of growth hormone vesicles from somatotrophic cells. In vitro assay data show that Hexarelin exhibits one of the highest intrinsic efficacies among non-natural peptide secretagogues for stimulating growth hormone release in isolated pituitary tissue models. For further technical analysis of secretagogue signaling cascades, explore our growth hormone secretagogues guide.
Beyond its actions at the GHSR-1a target site, preclinical literature highlights Hexarelin's unique affinity for the CD36 scavenger receptor. CD36 is a transmembrane glycoprotein involved in fatty acid transport, lipid homeostasis, and inflammatory signaling within cardiovascular and metabolic tissue models. In vitro binding assays demonstrate that Hexarelin interacts directly with the extracellular domain of CD36, independent of its GHSR-1a pathway.
In rodent cardiovascular research models, researchers have utilized Hexarelin to investigate myocardial ischemia-reperfusion injury, cardiomyocyte survival signaling, and fatty acid oxidation patterns. Because CD36 activation modulates cardiac metabolic substrates, Hexarelin serves as a dual-target molecular probe in cell culture systems designed to explore both endocrine secretion and localized receptor-mediated metabolic responses.
When designing comparative secretagogue protocols, investigators often analyze Hexarelin alongside other synthetic hexapeptides and ghrelin mimetics. While sharing a target receptor family, structural variations alter their potency, desensitization kinetics, and secondary binding profiles.
Compared to Ipamorelin, which exhibits selective GHSR-1a activation without significant secondary hormone displacement, Hexarelin demonstrates a higher peak growth hormone release amplitude in pituitary cell cultures, though it exhibits faster receptor desensitization upon continuous exposure. Relative to GHRP-6 and GHRP-2, Hexarelin features enhanced enzymatic stability due to its modified amino acid sequence. Additionally, when combined in synergistic research protocols with GHRH analogs such as CJC-1295, investigators observe distinct dual-receptor pathway activation in pituitary cell systems. Detailed cross-class comparisons are cataloged in our GHRP mechanism analysis.
Proper reconstitution of lyophilizates is vital to maintaining structural integrity and preventing peptide aggregation. Hexarelin is supplied as a sterile lyophilized cake that requires cautious solubilization under aseptic laboratory conditions inside a certified laminar flow hood.
To reconstitute, researchers should add sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile Phosphate-Buffered Saline (PBS, pH 7.4) down the internal glass wall of the vial. Direct high-velocity injection onto the lyophilized powder must be avoided to prevent mechanical shear stress. Gentle swirl motion—never vigorous vortexing—should be employed until complete dissolution is observed. Reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated thermal cycling during protocol execution.
To preserve long-term potency and prevent hydrolytic degradation, strict storage parameters must be enforced in the laboratory facility:
1. Lyophilized Powder: Store at -20°C in a manual defrost freezer protected from light. Under these conditions, the un-reconstituted peptide remains stable for up to 24 months. 2. Reconstituted Solutions: Store stock aliquots at 2°C to 8°C for short-term use (up to 30 days when reconstituted with bacteriostatic water). For long-term storage of liquid formulations, freeze aliquots at -80°C. 3. Freeze-Thaw Prevention: Avoid repeated freeze-thaw cycles, which induce mechanical stress on the peptide backbone and lead to irreversible aggregation or structural degradation.
Detailed storage handling protocols are maintained in the PX1 Research library for laboratory staff reference.
When procuring Hexarelin product materials for empirical testing, verifying analytical purity is non-negotiable. Substandard peptide preparations containing sequence errors or synthesis reagents can compromise baseline assay readings and invalidate experimental outcomes.
PX1 Research mandates rigorous quality assurance for every single lot. Quality standards include: - Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC): Ensures purity levels equal to or exceeding 99.0%, identifying and eliminating truncation sequences. - Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass (887.04 g/mol) and identity. - Bacterial Endotoxin Testing (LAL Assay): Guarantees endotoxin levels fall strictly below <0.01 EU/μg to prevent inflammatory interference in cell cultures. - ISO 17025 Accreditation: Analytical testing is conducted in independent ISO 17025 accredited laboratories to ensure uncompromised data integrity.
Sourcing research-grade compounds requires a transparent supply chain backed by rigorous operational standards. PX1 Research manufactures peptides in state-of-the-art GMP-compliant facilities within the USA, ensuring total batch traceability and batch-to-batch consistency.
Orders are processed and dispatched directly from primary dispatch centers in California and Arizona, with same-day shipping offered Monday through Friday for seamless laboratory logistics. Principal investigators and procurement officers interested in volume institutional sourcing can establish institutional accounts via our bulk research accounts portal.
What is the primary scientific classification of Hexarelin?
Hexarelin is classified as a synthetic hexapeptide growth hormone secretagogue (GHS) and selective ghrelin receptor agonist. It is intended strictly for in vitro, cellular, and preclinical laboratory research.
What does 'Hexarelin peptide koop' refer to?
The phrase reflects international research procurement queries seeking to purchase ('koop') high-grade, synthetically verified Hexarelin for academic and laboratory research applications.
How does Hexarelin differ structurally from native ghrelin?
Hexarelin is an engineered hexapeptide incorporating unnatural D-amino acids (D-Trp, D-Phe) that protect against enzymatic degradation. Unlike native ghrelin, it does not require serine n-octanoylation to bind and activate the GHSR-1a receptor.
Which molecular receptors does Hexarelin interact with in research models?
Hexarelin primarily targets the growth hormone secretagogue receptor 1a (GHSR-1a) in pituitary and hypothalamic tissue models. Secondarily, preclinical studies demonstrate binding affinity for the CD36 scavenger receptor in cardiovascular and metabolic tissue assays.
What analytical documents are provided with PX1 Research Hexarelin lots?
Every lot of Hexarelin from PX1 Research is accompanied by a downloadable Certificate of Analysis (COA) detailing RP-HPLC purity profiles, mass spectrometry verification, and bacterial endotoxin (LAL) testing results.
What is the recommended reconstitution diluent for lab assays?
Reconstitution is typically performed using sterile Bacteriostatic Water (0.9% benzyl alcohol) for routine storage or sterile Phosphate-Buffered Saline (PBS, pH 7.4) for immediate cell culture applications under sterile conditions.
What endotoxin thresholds are enforced for PX1 Research peptides?
PX1 Research enforces a strict endotoxin threshold of <0.01 EU/μg verified by Limulus Amebocyte Lysate (LAL) assay to ensure cell culture compatibility and prevent non-specific immune reactions in vitro.
How should reconstituted Hexarelin stock solutions be stored?
Reconstituted stock solutions should be divided into single-use aliquots and stored at 2°C to 8°C for short-term use (up to 30 days) or -80°C for extended storage to prevent degradation and avoid freeze-thaw cycles.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.